Search

QUALITY & DATA ANALYST RN - ONCOLOGY

IL-Springfield,

Moderna Ends “Venture” Experiment, Dissolves Four Startups

MODERNA ENDS “VENTURE” EXPERIMENT, DISSOLVES FOUR STARTUPS

Moderna Therapeutics, the high-flying private company with a $1 billion war chest, is reversing course. Three years ago, it decided...

 
 
 
Stop prostate cancer dead in its tracks by eating apples and grapes, reveals new research

STOP PROSTATE CANCER DEAD IN ITS TRACKS BY EATING APPLES AND GRAPES, REVEALS NEW RESEARCH

Eating apples and grapes may help stave off prostate cancer onset, the most common cancer among American men. As reported by Nature.com,...

Immunotherapy Safety Worries Halt Celgene Myeloma Study, Slow 5 Others

IMMUNOTHERAPY SAFETY WORRIES HALT CELGENE MYELOMA STUDY, SLOW 5 OTHERS

Amid growing concerns about the safety of a new class of cancer immunotherapy drugs when combined with other therapies to treat blood...

 
 
 
Notable Labs raises $10M for drug testing service to develop therapeutic index for oncologists

NOTABLE LABS RAISES $10M FOR DRUG TESTING SERVICE TO DEVELOP THERAPEUTIC INDEX FOR ONCOLOGISTS

The goal of the business is to help physicians identify the most suitable combinations of FDA-approved treatments that can be immediately...

Presage Bio Licenses Anti-Cancer Drug to San Diego's MEI Pharma

PRESAGE BIO LICENSES ANTI-CANCER DRUG TO SAN DIEGO'S MEI PHARMA

San Diego's MEI Pharma has agreed to pay $2.9 million upfront to Seattle-based Presage Biosciences for exclusive worldwide rights for...

 
 
 

ASSOCIATE DIRECTOR GLOBAL ONCOLOGY R&D

IMPORTANT NOTE: We are very pleased to announce the location of Daiichi Sankyo, Inc.'s new US headquarters where our Parsippany- and...

Dr. Shyirambere: Cancer is No Longer a Death Sentence in Rwanda

DR. SHYIRAMBERE: CANCER IS NO LONGER A DEATH SENTENCE IN RWANDA

Photos by Cecille Joan Avila / Partners In Health Dr. Cyprien Shyirambere, oncology program associate director, fills out paperwork...

 
 
 
What stands in the way of precision medicine's advancement? Inadequate infrastructure for data collection

WHAT STANDS IN THE WAY OF PRECISION MEDICINE'S ADVANCEMENT? INADEQUATE INFRASTRUCTURE FOR DATA COLLECTION

Tailoring data to the individual - distilling it down from the population level, in other words - is what's necessary for precision...

 
 
 

IMMUNOMIC WELCOMES NEW ONCOLOGY ADVISOR

Life Sciences Jobs ...

Invenra Signs On With Merck in Antibody Discovery Partnership

INVENRA SIGNS ON WITH MERCK IN ANTIBODY DISCOVERY PARTNERSHIP

Invenra has had success developing therapeutic antibodies for its own drug research, and for the research of others. Now the Madison,...

 
 
 
Merck Drug Shows No Life-Extending Benefit in Head-and-Neck Cancer

MERCK DRUG SHOWS NO LIFE-EXTENDING BENEFIT IN HEAD-AND-NECK CANCER

The first immunotherapy approved in the U.S. to treat head and neck cancer has failed a big test, but it's unclear if the FDA will...

 
 
 
MD Anderson chief innovation officer: “Innovation doesn't have to be sexy”

MD ANDERSON CHIEF INNOVATION OFFICER: “INNOVATION DOESN'T HAVE TO BE SEXY”

Rebecca Kaul, chief innovation officer at MD Anderson Cancer Center and a keynote speaker at MedCity CONVERGE, discussed why innovation...

INSYSBIO RELEASE: TO PREDICT UNPREDICTABLE: A PLATFORM FOR MODELING OF THE HIGH-SELECTIVE ONCOLOGY DRUGS WAS CREATED

Life Sciences Jobs ...

 
 
 
Proscia wants to bridge technology gap in cancer research

PROSCIA WANTS TO BRIDGE TECHNOLOGY GAP IN CANCER RESEARCH

In addition to its cloud-based products for digital pathology, Proscia has released nine image analysis modules targeting prostate,...

HEMISPHERX UPDATES STATUS OF IMMUNO-ONCOLOGY PROGRAM IN PANCREATIC CANCER

Life Sciences Jobs ...

 
 
 
One Health Company balances improving biomedical research and ethical animal testing

ONE HEALTH COMPANY BALANCES IMPROVING BIOMEDICAL RESEARCH AND ETHICAL ANIMAL TESTING

Since last year, The One Health Company has increased the trial site partners it collaborates with - veterinary hospitals and animal...

MOUNT TAM BIOTECHNOLOGIES ANNOUNCES CONTINUING ONCOLOGY FOCUS

Life Sciences Jobs ...